A study has revealed that IGF2BP3 stabilized CDKN2B-AS1 to promote the progression of renal clear cell carcinoma via epigenetically activating NUF2 transcription [45]. The gene discussed is IGF2BP3; the disease is clear cell renal carcinoma.